Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration
about
Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeysEffects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys.Agonist Medications for the Treatment of Cocaine Use DisorderAbuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeysChoice between delayed food and immediate oxycodone in ratsThe development of a preference for cocaine over food identifies individual rats with addiction-like behaviorsEffects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys.Monoamine transporter inhibitors and substrates as treatments for stimulant abuseNoribogaine reduces nicotine self-administration in rats.Rate-dependent effects of monoamine releasers on intracranial self-stimulation in rats: implications for abuse liability assessment.Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeysA review of human drug self-administration procedures.Attenuated neural response to emotional cues in cocaine-dependence: a preliminary analysis of gender differences.Drug specificity in drug versus food choice in male rats.William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants.A generalized matching law analysis of cocaine vs. food choice in rhesus monkeys: effects of candidate 'agonist-based' medications on sensitivity to reinforcement.Effects of quetiapine treatment on cocaine self-administration and behavioral indices of sleep in adult rhesus monkeys.Effects of oral and intravenous administration of buspirone on food-cocaine choice in socially housed male cynomolgus monkeys.Concurrent access to nicotine and sucrose in ratsUse of Preclinical Drug vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine AddictionPreclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure.Persistent palatable food preference in rats with a history of limited and extended access to methamphetamine self-administrationEffect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model.Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeys.Cocaine choice procedures in animals, humans, and treatment-seekers: Can we bridge the divide?Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm.Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys.Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging.Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeysEffect of delay on self-administration of remifentanil under a drug versus drug choice procedure in rhesus monkeysThe relative reinforcing strength of methamphetamine and D-amphetamine in monkeys self-administering cocaine.Recovering from cocaine: insights from clinical and preclinical investigations.Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.Modeling the development of drug addiction in male and female animals.Utility of Nonhuman Primates in Substance Use Disorders Research.Insights from Preclinical Choice Models on Treating Drug Addiction.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques.
P2860
Q27305163-1DBB039A-A4BB-4A29-9BDC-77BD96A592EAQ27310677-2DF0A6FF-5E3F-409B-99EA-55783599DC17Q28087404-79ABAEFB-ADCF-4707-AE64-FDDA1684E4CDQ28239471-FF39E8CE-8CFE-42DA-8A1F-B0D1C7FA9A1EQ28393973-6DD6C906-BC67-483D-AAA4-0C896EA6094AQ28535240-542FC7CB-54FD-4F8B-AB1A-813A6856FED4Q30362023-B16B0039-1A40-4EE0-A5A1-B988C8B9046FQ30413718-A8AFD1C0-6782-4697-BADD-3495A6A2D898Q30653279-3A157BBC-09B6-45FD-8A43-AC40E952F56AQ33638031-1AC7D96D-A7FF-4D4C-8AC2-C36BDC206CA7Q33817945-E47FF523-AA91-425F-8FB6-A7106BFE9346Q33841805-755C0D57-C1A2-4687-8CD6-7B5C1FC58809Q33865499-AA78FC66-BC14-43D0-B13A-094B52B6FE7CQ34141953-B3926635-36A9-45DC-8BE9-C219FA3241FEQ34550795-9C0036C7-D417-4EC9-96C0-9448D2F74862Q34748883-39D14A85-0FAB-4DE3-A686-000BACE93626Q34979796-AB4AEFFB-7EF7-4778-BD90-4BFE42E41FFBQ35200015-95B747B1-137C-41C2-AFB3-6B57C7CD4B3FQ35305239-52089813-04CE-4E74-BD58-E3E8FE24B23EQ35636912-3C71EAEB-891C-4346-B24F-1F9B582AFA58Q35691213-6F2BCC44-58E8-480C-8E6F-A3E9548B195BQ35843550-83131D90-DFBC-4168-A171-B00583030892Q35988776-1D7DA717-8E77-4796-B718-FBB1133CF7D6Q36090475-316985F9-FFDA-402A-BBDD-117B6006FB1CQ36270654-3C7E6B17-A2D5-4C49-8523-BCADF7ADE5C4Q36581531-8C527048-2DFF-45A9-8460-B24F6293D0B7Q37018136-671B11C0-A543-4DDE-9F1E-E9981327D369Q37062538-EFCD7DCA-56C5-436F-97C5-2ECED9A68387Q37265838-23E7DA2E-AA51-4459-93CF-04BC94C13B58Q37309771-79BBBCBB-2E07-45C9-9FD2-BACB3F356516Q37331840-93409577-45AA-485D-A680-9864203A70D9Q37379150-A2489243-8AA3-4DF8-945F-B0EA2317D857Q37604557-80DF08C2-F21A-4755-9421-03843517D8F4Q38664308-7D50AC2D-9308-423E-AF87-E4BD242C9A8FQ38669858-E3B1A651-1E41-477C-8C3C-CCA383603F48Q38680773-7B272FA8-B386-4D80-AA2F-0054464C4AE3Q39028819-BC6698CF-0342-49B7-8890-6FFE29D32133Q39034288-F6B8768E-E1F0-4B84-AED9-65D77039260DQ39262233-D37BA48E-178D-4513-B4CB-832D1CB5F69DQ39327496-B0831CDA-F4ED-43DA-8417-A7E4B92E708B
P2860
Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Preclinical Determinants of Dr ...... es of Drug Self-Administration
@ast
Preclinical Determinants of Dr ...... es of Drug Self-Administration
@en
type
label
Preclinical Determinants of Dr ...... es of Drug Self-Administration
@ast
Preclinical Determinants of Dr ...... es of Drug Self-Administration
@en
prefLabel
Preclinical Determinants of Dr ...... es of Drug Self-Administration
@ast
Preclinical Determinants of Dr ...... es of Drug Self-Administration
@en
P2860
P356
P1476
Preclinical Determinants of Dr ...... es of Drug Self-Administration
@en
P2093
Matthew L Banks
S Stevens Negus
P2860
P304
P356
10.1155/2012/281768
P577
2012-11-28T00:00:00Z